Emerging principles governing signal transduction by Pattern-Recognition receptors

Cold Spring Harbor Perspectives in Biology

Volumn 7, Issue 3, 2015, Pages

  Kagan, Jonathan C ^a   Barton, Gregory M ^b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIA;

CELL RECEPTOR; NUCLEIC ACID; PLAKIN; TOLL LIKE RECEPTOR;

ANIMAL; BIOLOGICAL MODEL; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; IMMUNITY, INNATE; MODELS, IMMUNOLOGICAL; NUCLEIC ACIDS; PLAKINS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 84924794747     PISSN: None     EISSN: 19430264     Source Type: Journal    
DOI: 10.1101/cshperspect.a016253     Document Type: Article

References (123)

1. Ablasser A, Bauernfeind F, Hartmann G, Latz E, Fitzgerald KA, Hornung V. 2009. RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate. Nat Immunol 10: 1065–1072.
2. Ablasser A, Goldeck M, Cavlar T, Deimling T, Witte G, Rohl I, Hopfner KP, Ludwig J, Hornung V. 2013. cGAS produces a 20-50-linked cyclic dinucleotide second messenger that activates STING. Nature 498: 380–384.
3. Aksoy E, Taboubi S, Torres D, Delbauve S, Hachani A, Whitehead MA, Pearce WP, Berenjeno IM, Nock G, Fil-loux A, et al. 2012. The pp110d isoform of the kinase PI(3)K controls the subcellular compartmentalization of TLR4 signaling and protects from endotoxic shock. Nat Immunol 13: 1045–1054.
4. Arpaia N, Godec J, Lau L, Sivick KE, McLaughlin LM, Jones MB, Dracheva T, Peterson SN, Monack DM, Barton GM. 2011. TLR signaling is required for Salmonella typhimu-rium virulence. Cell 144: 675–688.
5. Avalos AM, Kirak O, Oelkers JM, Pils MC, Kim YM, Ottinger M, Jaenisch R, Ploegh HL, Brinkmann MM. 2013. Cell-specific TLR9 trafficking in primary APCs of transgenic TLR9-GFP mice. J Immunol 190: 695–702.
6. Barbalat R, Lau L, Locksley RM, Barton GM. 2009. Toll-like receptor 2 on inflammatory monocytes induces type I interferon in response to viral but not bacterial ligands. Nat Immunol 10: 1200–1207.
7. Barton GM, Kagan JC. 2009. A cell biological view of Tolllike receptor function: Regulation through compartmen-talization. Nat Rev Immunol 9: 535–542.
8. Barton GM, Kagan JC, Medzhitov R. 2006. Intracellular localization of Toll-like receptor 9 prevents recognition of self-DNA but facilitates access to viral DNA. Nat Immunol 7: 49–56.
9. Baumann CL, Aspalter IM, Sharif O, Pichlmair A, Bluml S, Grebien F, Bruckner M, Pasierbek P, Aumayr K, Planyav-sky M, et al. 2010. CD14 is a coreceptor of Toll-like receptors 7 and 9. J Exp Med 207: 2689–2701.
10. Belgnaoui SM, Paz S, Hiscott J. 2011. Orchestrating the interferon antiviral response through the mitochondrial antiviral signaling (MAVS) adapter. Curr Opin Immunol 23: 564–572.
11. Berke IC, Modis Y. 2012. MDA5 cooperatively forms dimers and ATP-sensitive filaments upon binding double-stranded RNA. EMBO J 31: 1714–1726.
12. Blander JM, Medzhitov R. 2004. Regulation of phagosome maturation by signals from Toll-like receptors. Science 304: 1014–1018.
13. Blander JM, Medzhitov R. 2006a. On regulation of phago-some maturation and antigen presentation. Nat Immunol 7: 1029–1035.
14. Blander JM, Medzhitov R. 2006b. Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 440: 808–812.
15. Blasius AL, Arnold CN, Georgel P, Rutschmann S, Xia Y, Lin P, Ross C, Li X, Smart NG, Beutler B. 2010. Slc15a4, AP-3, and Hermansky-Pudlak syndrome proteins are required for Toll-like receptor signaling in plasmacytoid dendritic cells. Proc Natl Acad Sci 107: 19973–19978.
16. Brinkmann MM, Spooner E, Hoebe K, Beutler B, Ploegh HL, Kim Y-M. 2007. The interaction between the ER membrane protein UNC93B and TLR3,7, and 9iscrucial for TLR signaling. J Cell Biol 177: 265–275.
17. Burdette DL, Vance RE. 2013. STING and the innate immune response to nucleic acids in the cytosol. Nat Immunol 14: 19–26.
18. Chen Z, Benureau Y, Rijnbrand R, Yi J, Wang T, Warter L, Lanford RE, Weinman SA, Lemon SM, Martin A, et al. 2007. GB virus B disrupts RIG-I signaling by NS3/4A-mediated cleavage of the adaptor protein MAVS. J Virol 81: 964–976.
19. Chiang CY, Veckman V, Limmer K, David M. 2012. Phos-pholipase Cg-2 and intracellular calcium are required for lipopolysaccharide-induced Toll-like receptor 4 (TLR4) endocytosis and interferon regulatory factor 3 (IRF3) activation. J Biol Chem 287: 3704–3709.
20. Chiu Y-H, MacMillan JB, Chen ZJ. 2009. RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell 138: 576–591.
21. Diner EJ, Burdette DL, Wilson SC, Monroe KM, Kellen-berger CA, Hyodo M, Hayakawa Y, Hammond MC, Vance RE. 2013. The innate immune DNA sensor cGAS produces a noncanonical cyclic dinucleotide that activates human STING. Cell Rep 3: 1355–1361.
22. Dixit E, Boulant S, Zhang Y, Lee AS, Odendall C, Shum B, Hacohen N, Chen ZJ, Whelan SP, Fransen M, et al. 2010. Peroxisomes are signaling platforms for antiviral innate immunity. Cell 141: 668–681.
23. Esparza GA, Teghanemt A, Zhang D, Gioannini TL, Weiss JP. 2012. Endotoxin albumin complexes transfer endotoxin † monomers to MD-2 resulting in activation of TLR4. Innate Immun 18: 478–491.
24. Ewald SE, Lee BL, Lau L, Wickliffe KE, Shi GP, Chapman HA, Barton GM. 2008. The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor. Nature 456: 658–662.
25. Ewald SE, Engel A, Lee J, Wang M, Bogyo M, Barton GM. 2011. Nucleic acid recognition by Toll-like receptors is coupled to stepwise processing by cathepsins and aspar-agine endopeptidase. J Exp Med 208: 643–651.
26. Flannagan RS, Jaumouille V, Grinstein S. 2012. The cell biology of phagocytosis. Annu Rev Pathol 7: 61–98.
27. Fukui R, Saitoh S-I, Matsumoto F, Kozuka-Hata H, Oyama M, Tabeta K, Beutler B, Miyake K. 2009. Unc93B1 biases Toll-like receptor responses to nucleic acid in dendritic cells toward DNA- but against RNA-sensing. J Exp Med 206: 1339–1350.
28. Fukui R, Saitoh S, Kanno A, Onji M, Shibata T, Ito A, Mat-sumoto M, Akira S, Yoshida N, Miyake K. 2011. Unc93B1 restricts systemic lethal inflammation by orchestrating Toll-like receptor 7 and 9 trafficking. Immunity 35: 69–81.
29. Gao D, Wu J, Wu YT, Du F, Aroh C, Yan N, Sun L, Chen ZJ. 2013a. Cyclic GMP-AMP synthase is an innate immune sensor of HIV and other retroviruses. Science 341: 903– 906.
30. Gao P, Ascano M, Wu Y, Barchet W, Gaffney BL, Zillinger T, Serganov AA, Liu Y, Jones RA, Hartmann G, et al. 2013b. Cyclic [G(20,50)pA(30,50)p] is the metazoan second messenger produced by DNA-activated cyclic GMP-AMP synthase. Cell 153: 1094–1107.
31. Garcia-Cattaneo A, Gobert FX, Muller M, Toscano F, Flores M, Lescure A, Del Nery E, Benaroch P. 2012. Cleavage of Toll-like receptor 3 by cathepsins B and H is essential for signaling. Proc Natl Acad Sci 109: 9053–9058.
32. Geijtenbeek TB, Gringhuis SI. 2009. Signalling through C-type lectin receptors: Shaping immune responses. Nat Rev Immunol 9: 465–479.
33. Gioannini TL, Zhang D, Teghanemt A, Weiss JP. 2002. An essential role for albumin in the interaction of endotoxin with lipopolysaccharide-binding protein and sCD14 and resultant cell activation. J Biol Chem 277: 47818–47825.
34. Gioannini TL, Teghanemt A, Zhang D, Coussens NP, Dock-stader W, Ramaswamy S, Weiss JP. 2004. Isolation of an endotoxin-MD-2 complex that produces Toll-like receptor 4-dependent cell activation at picomolar concentrations. Proc Natl Acad Sci 101: 4186–4191.
35. Hart BE, Tapping RI. 2012. Cell surface trafficking of TLR1 is differentially regulated by the chaperones PRAT4A and PRAT4B. J Biol Chem 287: 16550–16562.
36. Henault J, Martinez J, Riggs JM, Tian J, Mehta P, Clarke L, Sasai M, Latz E, Brinkmann MM, Iwasaki A, et al. 2012. Noncanonical autophagy is required for type I interferon secretion in response to DNA-immune complexes. Immunity 37: 986–997.
37. Henneke P, Takeuchi O, van Strijp JA, Guttormsen HK, Smith JA, Schromm AB, Espevik TA, Akira S, Nizet V, Kasper DL, et al. 2001. Novel engagement of CD14 and multiple Toll-like receptors by group B streptococci. J Immunol 167: 7069–7076.
38. Herre J, Marshall AS, Caron E, Edwards AD, Williams DL, Schweighoffer E, Tybulewicz V, Reis e Sousa C, Gordon S, Brown GD. 2004. Dectin-1 uses novel mechanisms for yeast phagocytosis in macrophages. Blood 104: 4038– 4045.
39. Hipp MM, Shepherd D, Gileadi U, Aichinger MC, Kessler BM, Edelmann MJ, Essalmani R, Seidah NG, Reis ESC, Cerundolo V. 2013. Processing of human Toll-like receptor 7 by furin-like proprotein convertases is required for its accumulation and activity in endosomes. Immunity 39: 711–721.
40. Hoebe K, Georgel P, Rutschmann S, Du X, Mudd S, Crozat K, Sovath S, Shamel L, Hartung T, Zahringer U, et al. 2005. CD36 is a sensor of diacylglycerides. Nature 433: 523–527.
41. Honda K, Ohba Y, Yanai H, Negishi H, Mizutani T, Takaoka A, Taya C, Taniguchi T. 2005. Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature 434: 1035–1040.
42. Horner SM, Liu HM, Park HS, Briley J, Gale M Jr. 2011. Mitochondrial-associated endoplasmic reticulum membranes (MAM) form innate immune synapses and are targeted by hepatitis C virus. Proc Natl Acad Sci 108: 14590–14595.
43. Hou F, Sun L, Zheng H, Skaug B, Jiang QX, Chen ZJ. 2011. MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response. Cell 146: 448–461.
44. Husebye H, Aune MH, Stenvik J, Samstad E, Skjeldal F, Halaas O, Nilsen NJ, Stenmark H, Latz E, Lien E, et al. 2010. The Rab11a GTPase controls Toll-like receptor 4-induced activation of interferon regulatory factor-3 on phagosomes. Immunity 33: 583–596.
45. Ip WK, Takahashi K, Moore KJ, Stuart LM, Ezekowitz RA. 2008. Mannose-binding lectin enhances Toll-like receptors 2 and 6 signaling from the phagosome. J Exp Med 205: 169–181.
46. Ishikawa H, Barber GN. 2008. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455: 674–678.
47. Ishikawa H, Ma Z, Barber GN. 2009. STING regulates intracellular DNA-mediated, type I interferon-depen-dent innate immunity. Nature 461: 788–792.
48. Iwasaki A, Medzhitov R. 2010. Regulation of adaptive immunity by the innate immune system. Science 327: 291–295.
49. Jain V, Halle A, Halmen KA, Lien E, Charrel-Dennis M, Ram S, Golenbock DT, Visintin A. 2008. Phagocytosis and intracellular killing of MD-2 opsonized Gram-negative bacteria depend on TLR4 signaling. Blood 111: 4637–4645.
50. Janeway CA Jr. 1989. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol 54: 1–13.
51. Janeway CA Jr, Medzhitov R. 2002. Innate immune recognition. Annu Rev Immunol 20: 197–216.
52. Kadowaki N, Ho S, Antonenko S, Malefyt RW, Kastelein RA, Bazan F, Liu YJ. 2001. Subsets of human dendritic cell precursors express different Toll-like receptors and respond to different microbial antigens. J Exp Med 194: 863–869.
53. Kagan JC. 2012. Signaling organelles of the innate immune system. Cell 151: 1168–1178.
54. Kagan J, Medzhitov R. 2006. Phosphoinositide-mediated adaptor recruitment controls Toll-like receptor signaling. Cell 125: 943–955.
55. Kagan JC, Su T, Horng T, Chow A, Akira S, Medzhitov R. 2008. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-b. Nat Immunol 9: 361–368.
56. Kawai T, Akira S. 2010. The role of pattern-recognition receptors in innate immunity: Update on Toll-like receptors. Nat Immunol 11: 373–384.
57. Kim HM, Park BS, Kim J-I, Kim SE, Lee J, Oh SC, Enkhbayar P, Matsushima N, Lee H, Yoo OJ, et al. 2007. Crystal structure of the TLR4-MD-2 complex with bound endo-toxin antagonist Eritoran. Cell 130: 906–917.
58. Kim YM, Brinkmann MM, Paquet ME, Ploegh HL. 2008. UNC93B1 delivers nucleotide-sensing Toll-like receptors to endolysosomes. Nature 452: 234–238.
59. Kim J, Huh J, Hwang M, Kwon EH, Jung DJ, Brinkmann MM, Jang MH, Ploegh HL, Kim YM. 2013. Acidic amino acid residues in the juxtamembrane region of the nucle-otide-sensing TLRs are important for UNC93B1 binding and signaling. J Immunol 190: 5287–5295.
60. Koblansky AA, Jankovic D, Oh H, Hieny S, Sungnak W, Mathur R, Hayden MS, Akira S, Sher A, Ghosh S. 2012. Recognition of profilin by Toll-like receptor 12 is critical for host resistance to Toxoplasma gondii. Immunity 38: 119–130.
61. Kranzusch PJ, Lee AS, Berger JM, Doudna JA. 2013. Structure of human cGAS reveals a conserved family of second-messenger enzymes in innate immunity. Cell Rep 3: 1362–1368.
62. Lamkanfi M, Dixit VM. 2012. Inflammasomes and their roles in health and disease. Annu Rev Cell Dev Biol 28: 137–161.
63. Lee HK, Dunzendorfer S, Soldau K, Tobias PS. 2006a. Double-stranded RNA-mediated TLR3 activation is enhanced by CD14. Immunity 24: 153–163.
64. Lee J, Mo J-H, Katakura K, Alkalay I, Rucker AN, Liu Y-T, Lee H-K, Shen C, Cojocaru G, Shenouda S, et al. 2006b. Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells. Nat Cell Biol 8: 1327–1336.
65. Lee HK, Lund JM, Ramanathan B, Mizushima N, Iwasaki A. 2007. Autophagy-dependent viral recognition by plas-macytoid dendritic cells. Science 315: 1398–1401.
66. Lee BL, Moon JE, Shu JH, Yuan L, Newman ZR, Schekman R, Barton GM. 2013. UNC93B1 mediates differential trafficking of endosomal TLRs. Elife 2: e00291.
67. Levine B, Mizushima N, Virgin HW. 2011. Autophagy in immunity and inflammation. Nature 469: 323–335.
68. Li XD, Sun L, Seth RB, Pineda G, Chen ZJ. 2005. Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc Natl Acad Sci 102: 17717–17722.
69. Li XD, Wu J, Gao D, Wang H, Sun L, Chen ZJ. 2013. Pivotal roles of cGAS–cGAMP signaling in antiviral defense and immune adjuvant effects. Science 341: 1390–1394.
70. Lin YC, Huang DY, Chu CL, Lin YL, Lin WW. 2013. The tyrosine kinase Syk differentially regulates Toll-like receptor signaling downstream of the adaptor molecules TRAF6 and TRAF3. Sci Signal 6: ra71.
71. Lindau D, Mussard J, Wagner BJ, Ribon M, Ronnefarth VM, Quettier M, Jelcic I, Boissier MC, Rammensee HG, Decker P. 2013. Primary blood neutrophils express a functional cell surface Toll-like receptor 9. Eur J Immunol 43: 2101–2113.
72. Mansell A, Smith R, Doyle SL, Gray P, Fenner JE, Crack PJ, Nicholson SE, Hilton DJ, O’Neill LA, Hertzog PJ. 2006. Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation. Nat Immunol 7: 148–155.
73. Manzanillo PS, Shiloh MU, Portnoy DA, Cox JS. 2012. My-cobacterium tuberculosis activates the DNA-dependent cytosolic surveillance pathway within macrophages. Cell Host Microbe 11: 469–480.
74. Marek LR, Kagan JC. 2012. Phosphoinositide bindingby the Toll adaptor dMyD88 controls antibacterial responses in Drosophila. Immunity 36: 612–622.
75. Martinez J, Almendinger J, Oberst A, Ness R, Dillon CP, Fitzgerald P, Hengartner MO, Green DR. 2011. Microtu-bule-associated protein1 light chain3 a(LC3)-associated phagocytosis is required for the efficient clearance of dead cells. Proc Natl Acad Sci 108: 17396–17401.
76. Mathur R, Oh H, Zhang D, Park SG, Seo J, Koblansky A, Hayden MS, Ghosh S. 2012. A mouse model of Salmonella typhi infection. Cell 151: 590–602.
77. Matsumoto M, Funami K, Tanabe M, Oshiumi H, Shingai M, Seto Y, Yamamoto A, Seya T. 2003. Subcellular localization of Toll-like receptor 3 in human dendritic cells. J Immunol 171: 3154–3162.
78. Mouchess ML, Arpaia N, Souza G, Barbalat R, Ewald SE, Lau L, Barton GM. 2011. Transmembrane mutations in Toll-like receptor 9 bypass the requirement for ectodo-main proteolysis and induce fatal inflammation. Immunity 35: 721–732.
79. Onji M, Kanno A, Saitoh S, Fukui R, Motoi Y, Shibata T, Matsumoto F, Lamichhane A, Sato S, Kiyono H, et al. 2013. An essential role for the N-terminal fragment of Toll-like receptor 9 in DNA sensing. Nat Commun 4: 1949.
80. Osorio F, Reis e Sousa C. 2011. Myeloid C-type lectin receptors in pathogen recognition and host defense. Immunity 34: 651–664.
81. Park B, Brinkmann MM, Spooner E, Lee CC, Kim Y-M, Ploegh HL. 2008. Proteolytic cleavage in an endolysoso-mal compartment is required for activation of Toll-like receptor 9. Nat Immunol 9: 1407–1414.
82. Park BS, Song DH, Kim HM, Choi BS, Lee H, Lee JO. 2009. The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature 458: 1191–1195.
83. Peisley A, Wu B, Yao H, Walz T, Hur S. 2013. RIG-I forms signaling-competent filaments in an ATP-dependent, ubiquitin-independent manner. Mol Cell 51: 573–583.
84. Peter ME, Kubarenko AV, Weber ANR, Dalpke AH. 2009. Identification of an N-terminal recognition site in TLR9 that contributes to CpG-DNA-mediated receptor activation. J Immunol 182: 7690–7697.
85. Pichlmair A, Schulz O, Tan CP, Näslund TI, Liljeström P, Weber F, Reis e Sousa C. 2006. RIG-I-mediated antiviral responsesto single-stranded RNA bearing 50-phosphates. Science 314: 997–1001.
86. Pichlmair A, Schulz O, Tan CP, Rehwinkel J, Kato H, Take-uchi O, Akira S, Way M, Schiavo G, Reis e Sousa C. 2009. Activation of MDA5 requires higher-order RNA structures generated during virus infection. J Virol 83: 10761– 10769.
87. Pifer R, Benson A, Sturge CR, Yarovinsky F. 2011. UNC93B1 is essential for TLR11 activation and IL-12-dependent host resistance to Toxoplasma gondii. J Biol Chem 286: 3307–3314.
88. Pohar J, Pirher N, Bencina M, Mancek-Keber M, Jerala R. 2013. The role of UNC93B1 in surface localization of TLR3 and in cell priming to nucleic acid agonists. J Biol Chem 288: 442–454.
89. Prohinar P, Re F, Widstrom R, Zhang D, Teghanemt A, Weiss JP, Gioannini TL. 2007. Specific high affinity interactions of monomeric endotoxin protein complexes with Toll-† like receptor 4 ectodomain. J Biol Chem 282: 1010–1017.
90. Rathinam VA, Fitzgerald KA. 2011. Cytosolic surveillance and antiviral immunity. Curr Opin Virol 1: 455–462.
91. Rehwinkel J, Tan CP, Goubau D, Schulz O, Pichlmair A, Bier K, Robb N, Vreede F, Barclay W, Fodor E, et al. 2010. RIG-I detects viral genomic RNA during negative-strand RNA virus infection. Cell 140: 397–408.
92. Resman N, Vasl J, Oblak A, Pristovsek P, Gioannini TL, Weiss JP, Jerala R. 2009. Essential roles of hydrophobic residues in both MD-2 and Toll-like receptor 4 in activation by endotoxin. J Biol Chem 284: 15052–15060.
93. Rowe DC, McGettrick AF, Latz E, Monks BG, Gay NJ, Yamamoto M, Akira S, O’Neill LA, Fitzgerald KA, Go-lenbock DT. 2006. The myristoylation of TRIF-related adaptor molecule is essential for Toll-like receptor 4 signal transduction. Proc Natl Acad Sci 103: 6299–6304.
94. Russell DG, Yates RM. 2007. Toll-like receptors and phag-osome maturation. Nat Immunol 8: 217; author reply 217–218.
95. Rutz M, Metzger J, Gellert T, Luppa P, Lipford GB, Wagner H, Bauer S. 2004. Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence- and pH-dependent manner. Eur J Immunol 34: 2541–2550.
96. Saito T, Owen DM, Jiang F, Marcotrigiano J, Gale M Jr. 2008. Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature 454: 523–527.
97. Saitoh T, Fujita N, Hayashi T, Takahara K, Satoh T, Lee H, Matsunaga K, Kageyama S, Omori H, Noda T, et al. 2009. Atg9a controls dsDNA-driven dynamic translocation of STING and the innate immune response. Proc Natl Acad Sci 106: 20842–20846.
98. Sancho D, Reis eSousa C.2012. Signalingby myeloid C-type lectin receptors in immunity and homeostasis. Annu Rev Immunol 30: 491–529.
99. Sanjuan MA, Dillon CP, Tait SW, Moshiach S, Dorsey F, Connell S, Komatsu M, Tanaka K, Cleveland JL, Withoff S, et al. 2007. Toll-like receptor signalling in macrophages links the autophagy pathway to phagocytosis. Nature 450: 1253–1257.
100. Sasai M, Linehan MM, Iwasaki A. 2010. Bifurcation of Tolllike receptor 9signaling byadaptor protein3. Science 329: 1530–1534.
101. Sepulveda FE, Maschalidi S, Colisson R, Heslop L, Ghirelli C, Sakka E, Lennon-Duménil A-M, Amigorena S, Ca-banie L, Manoury B. 2009. Critical role for asparagine endopeptidasein endocytic Toll-like receptor signaling in dendritic cells. Immunity 31: 737–748.
102. Seth RB, Sun L, Ea CK, Chen ZJ. 2005. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kB and IRF3. Cell 122: 669–682.
103. Sun L, Wu J, Du F, Chen X, Chen ZJ. 2013.Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 339: 786–791.
104. Takahashi K, Shibata T, Akashi-Takamura S, Kiyokawa T, Wakabayashi Y, Tanimura N, Kobayashi T, Matsumoto F, Fukui R, Kouro T, et al. 2007. A protein associated with Toll-like receptor (TLR) 4 (PRAT4A) is required for TLR-dependent immune responses. J Exp Med 204: 2963–2976.
105. Tanaka Y, Chen ZJ. 2012. STING specifies IRF3 phosphor-ylation by TBK1 in the cytosolic DNA signaling pathway. Sci Signal 5: ra20.
106. Tanimura N, Saitoh S, Matsumoto F, Akashi-Takamura S, Miyake K. 2008. Roles for LPS-dependent interaction and relocation of TLR4 and TRAM in TRIF-signaling. Biochem Biophys Res Commun 368: 94–99.
107. Teghanemt A, Prohinar P, Gioannini TL, Weiss JP. 2007. Transfer of monomeric endotoxin from MD-2 to CD14: Characterization and functional consequences. J Biol Chem 282: 36250–36256.
108. Teghanemt A, Widstrom RL, Gioannini TL, Weiss JP. 2008. Isolation of monomeric and dimeric secreted MD-2. Endotoxin.sCD14 and Toll-like receptor 4 ectodomain selectively react with the monomeric form of secreted MD-2. J Biol Chem 283: 21881–21889.
109. Triantafilou M, Miyake K, Golenbock DT, Triantafilou K. 2002. Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccha-ride-induced cell activation. J Cell Sci 115: 2603–2611.
110. Tseng P-H, Matsuzawa A, Zhang W, Mino T, Vignali DAA, Karin M. 2010. Different modes of ubiquitination of the adaptor TRAF3 selectively activate the expression of type I interferons and proinflammatorycytokines. Nat Immunol 11: 70–75.
111. Uzri D, Gehrke L. 2009. Nucleotide sequences and modifications that determine RIG-I/RNA binding and signaling activities. J Virol 83: 4174–4184.
112. Wang Y, Chen T, Han C, He D, Liu H, An H, Cai Z, Cao X. 2007. Lysosome-associated small Rab GTPase Rab7b negatively regulates TLR4 signaling in macrophages by promoting lysosomal degradation of TLR4. Blood 110: 962–971.
113. Wang D, Lou J, Ouyang C, Chen W, Liu Y, Liu X, Cao X, Wang J, Lu L. 2010. Ras-related protein Rab10 facilitates TLR4 signaling by promoting replenishment of TLR4 onto the plasma membrane. Proc Natl Acad Sci 107: 13806–13811.
114. Watson RO, Manzanillo PS, Cox JS. 2012. Extracellular M. tuberculosis DNA targets bacteria for autophagy by activating the host DNA-sensing pathway. Cell 150: 803–815.
115. West MA, Wallin RP, Matthews SP, Svensson HG, Zaru R, Ljunggren HG, Prescott AR, Watts C. 2004. Enhanced dendritic cell antigen capture via Toll-like receptor-induced actin remodeling. Science 305: 1153–1157.
116. Wu B, Peisley A, Richards C, Yao H, Zeng X, Lin C, Chu F, Walz T, Hur S. 2013a. Structural basis for dsRNA recog-nition,filament formation, and antiviral signal activation by MDA5. Cell 152: 276–289.
117. Wu J, Sun L, Chen X, Du F, Shi H, Chen C, Chen ZJ. 2013b. Cyclic GMP-AMP isan endogenous second messenger in innate immune signaling by cytosolic DNA. Science 339: 826–830.
118. Xu Y, Jagannath C, Liu XD, Sharafkhaneh A, Kolodziejska KE, Eissa NT. 2007. Toll-like receptor 4 is a sensor for autophagy associated with innate immunity. Immunity 27: 135–144.
119. Yang Y, Liang Y, Qu L, Chen Z, Yi M, Li K, Lemon SM. 2007a. Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor. Proc Natl Acad Sci 104: 7253–7258.
120. Yang Y, Liu B, Dai J, Srivastava PK, Zammit DJ, Lefrancois L, Li Z. 2007b. Heat shock protein gp96 is a master chaper-one for Toll-like receptors and is important in the innate function of macrophages. Immunity 26: 215–226.
121. Yarovinsky F, Zhang D, Andersen J, Bannenberg G, Serhan C, Hayden M, Hieny S, Sutterwala F, Flavell R, Ghosh S, et al. 2005. TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science 308: 1626–1629.
122. Zanoni I, Ostuni R, Marek LR, Barresi S, Barbalat R, Barton GM, Granucci F, Kagan JC. 2011. CD14 controls the LPS-induced endocytosis of Toll-like receptor 4. Cell 147: 868–880.
123. Zhang X, Shi H, Wu J, Sun L, Chen C, Chen ZJ. 2013. Cyclic GMP-AMP containing mixed phosphodiester linkages is an endogenous high-affinity ligand for STING. Mol Cell 51: 226–235.